Table 2.

Odds ratio and 95% confidence intervals for pancreatic cancer and Helicobacter pylori serology among all sampled subjects

Case (n = 353)Control (n = 353)OR (95%CI)b
AntibodyNo.PositiveNo.PositiveCrudeAdjusted
Overalla32592%32893%0.85 (0.49–1.49)0.86 (0.49–1.51)
GROEL30085%30085%0.98 (0.65–1.48)1.01 (0.67–1.52)
UREA28180%26675%1.26 (0.88–1.80)1.29 (0.89–1.86)
HP023123065%24569%0.82 (0.60–1.12)0.80 (0.58–1.11)
NAPA26074%26675%0.90 (0.64–1.27)0.91 (0.65–1.29)
HP030523867%25673%0.78 (0.56–1.07)0.79 (0.57–1.10)
HPAA17048%17148%0.98 (0.73–1.32)0.98 (0.73–1.33)
CAG_DELTA19555%20458%0.90 (0.67–1.21)0.90 (0.66–1.22)
CAGM13137%12636%1.06 (0.78–1.44)1.06 (0.78–1.44)
CAGA25873%25873%0.99 (0.71–1.38)1.00 (0.71–1.42)
HYUA27177%27778%0.90 (0.63–1.28)0.91 (0.64–1.30)
CATALASE28882%27177%1.32 (0.92–1.90)1.34 (0.93–1.92)
VACA23466%24369%0.88 (0.64–1.21)0.90 (0.66–1.23)
HCPC22664%22664%0.99 (0.73–1.35)1.01 (0.73–1.41)
CAD11633%11432%1.02 (0.75–1.40)1.04 (0.76–1.42)
OMP28882%29182%0.93 (0.63–1.36)0.96 (0.64–1.44)
  • aThe subjects are considered as H. pylori seropositive if the subject is seropositive to four or more antigens.

  • bORs and 95% CIs calculated using conditional logistic regression. The adjusted model was adjusted for age, number of cigarettes per day, and years smoked.